ConductScience.org, home

Paper6301366

Unusual mode of inhibition of Citrobacter freundii beta-lactamases by ceftriaxone.

Arisawa M and 2 others. Antimicrob Agents Chemother, 1983. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Unusual mode of inhibition of Citrobacter freundii beta-lactamases by ceftriaxone. Papers, record 6301366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6301366

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unusual mode of inhibition of Citrobacter freundii beta-lactamases by ceftriaxone.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1983
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.61
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arisawa MM
2Ohshima JJ
3Maruyama HBH B

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
CefotaximeMajor topic
CitrobacterMajor topic
beta-Lactamase InhibitorsMajor topic
Ceftriaxone
Cephaloridine
Hydrolysis
Kinetics

Source PubMed

Download CSV of topics

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16967869Ro 13-9904/001, a novel potent and long-acting parenteral cephalosporin.J Antibiot (Tokyo)1980https://conductscience.org/library/papers/6967869PubMed
26973612Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391.J Gen Microbiol1980https://conductscience.org/library/papers/6973612PubMed
36983396Effect of 3-substitution in oxyiminocephalosporins on the stability to and the inhibition of various beta-lactamases.Chem Pharm Bull (Tokyo)1982https://conductscience.org/library/papers/6983396PubMed
46969574In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6969574PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
6610388Development of resistance to cephalosporins in clinical strains of Citrobacter spp.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6610388PubMed
6329638Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs1984https://conductscience.org/library/papers/6329638PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6301366

GET https://conductscience.org/api/papers/v1/6301366/authors